Evidence map›Paper›PMID 22759795›Full record

ReviewPharmacological reviews2012

Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling.

Richard Bridges, Victoria Lutgen, Doug Lobner, David A Baker

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacological reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 1 synthesis or guideline pooled it, 203 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Traumatic brain injury-related ferroptosis: current perspectives.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  7. Review
  8. Article
  9. Hydrogen sulfide/polysulfides signaling and neuronal diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Richard BridgesDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA.
Victoria Lutgen
Doug Lobner
David A Baker
Marquette University · USUniversity of Montana · US

Funding

Targeting System Xc- for the Treatment of SchizophreniaR44MH083417 · NIMH · PROMENTIS PHARMACEUTICALS, INC. · PI BAKER, DAVID A, BEYER, CHAD EDWARD · 2012 to 2014
$1.8M
Targeting System Xc- for the Treatment of AddictionR01DA025617 · NIDA · MARQUETTE UNIVERSITY · PI BAKER, DAVID A, COOK, JAMES M · 2009 to 2010
$1.4M
Development of Compounds Targeting xc- for the Treatment of SchizophreniaR43MH083417 · NIMH · PROMENTIS PHARMACEUTICALS, INC. · PI BAKER, DAVID A, COOK, JAMES M · 2008 to 2009
$508k
NIDA NIH HHS DA025617NIDA NIH HHS R01 DA025617NIMH NIH HHS MH083417NIMH NIH HHS R43 MH083417NIMH NIH HHS R44 MH083417
6 · The paper itself

Abstract

System x(c)(-) represents an intriguing target in attempts to understand the pathological states of the central nervous system. Also called a cystine-glutamate antiporter, system x(c)(-) typically functions by exchanging one molecule of extracellular cystine for one molecule of intracellular glutamate. Nonvesicular glutamate released during cystine-glutamate exchange activates extrasynaptic glutamate receptors in a manner that shapes synaptic activity and plasticity. These findings contribute to the intriguing possibility that extracellular glutamate is regulated by a complex network of release and reuptake mechanisms, many of which are unique to glutamate and rarely depicted in models of excitatory signaling. Because system x(c)(-) is often expressed on non-neuronal cells, the study of cystine-glutamate exchange may advance the emerging viewpoint that glia are active contributors to information processing in the brain. It is noteworthy that system x(c)(-) is at the interface between excitatory signaling and oxidative stress, because the uptake of cystine that results from cystine-glutamate exchange is critical in maintaining the levels of glutathione, a critical antioxidant. As a result of these dual functions, system x(c)(-) has been implicated in a wide array of central nervous system diseases ranging from addiction to neurodegenerative disorders to schizophrenia. In the current review, we briefly discuss the major cellular components that regulate glutamate homeostasis, including glutamate release by system x(c)(-). This is followed by an in-depth discussion of system x(c)(-) as it relates to glutamate release, cystine transport, and glutathione synthesis. Finally, the role of system x(c)(-) is surveyed across a number of psychiatric and neurodegenerative disorders.

Indexed as

Central Nervous SystemSynapsesAmino Acid Transport System y+AnimalsBiological TransportCystineGlutamic AcidGlutathioneHumansMental DisordersNeurodegenerative DiseasesNeurotoxicity SyndromesSignal TransductionAmino Acid Transport System y+CystineGlutamic AcidGlutathioneSLC7A11 protein, human

Identifiers

PMID22759795
PMCPMC3400835
OpenAlexW2133994038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.